Vaccinogen Inc


By |


Vaccinogen Inc is a biotechnology company focused on the development and commercialization of cancer vaccines and immunotherapeutic products for cancers. Its primary product is OncoVAX, an autologous cancer vaccine indicated for the post-surgical treatment of stage II colon cancer. The OncoVAX patient-specific vaccine consists of sterile, metabolically active, irradiated and non-tumorigenic autologous cancer cells, with or without fresh frozen Bacillus Calmette-Guerin (BCG) bacteria as an adjuvant.

Contact Information

Main Phone: +1 410 387-4000
Address: 949 Fell Street
State: MD
City / Town: Baltimore
Country: USA
Postal Code: 21231

Issuer Information

Exchange: CVEM
Employees: 24
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.00001 $ 0. (0.00%)
Last Price 0.00001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.00001 High 0.00001 Low 0.00001 Prev Close 0.00001
Last Trade Volume 2,000 52 Wk Hi 0.51 52 Wk Low 0.081
Market Cap 373 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,321,078.00 EPS (TTM) -0.80 PE Ratio N/A Exchange CV EM